Search

Displaying results 9701 - 9710 of 10000 in total
  1. Drug

    Brolucizumab

    go.drugbank.com/drugs/DB14864
    ApprovedInvestigational

    Brolucizumab, also known as RTH258 or ESBA1008,[A187211] is a monoclonal antibody indicated to treat neovascular age related macular degeneration.

    Products: VSIQQ® SOLUCION INYECTABLE, Xivubel 120 mg/ml Enjeksiyonluk Çözelti, 1 adet
  2. Drug

    Human interleukin-2

    go.drugbank.com/drugs/DB14865
    Investigational

    Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).

    Categories: Interleukin-2Synonyms: IL 2, IL-2
  3. Drug

    Amcasertib

    go.drugbank.com/drugs/DB14866
    Investigational

    Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).

  4. Drug

    AZD-8848

    go.drugbank.com/drugs/DB14868
    Investigational

    AZD-8848 is under investigation in clinical trial NCT01818869 (To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects).

    Categories: Heterocyclic Compounds, 2-Ring
  5. Drug

    PF-5190457

    go.drugbank.com/drugs/DB14870
    Investigational

    PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations In Healthy Volunteers).

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Enadenotucirev

    go.drugbank.com/drugs/DB14873
    Investigational

    Enadenotucirev is under investigation in clinical trial NCT02636036 (Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors).

  7. Drug

    Pimitespib

    go.drugbank.com/drugs/DB14876
    Investigational

    TAS-116 is under investigation in clinical trial NCT02965885 (A Study of TAS-116 in Patients With Solid Tumors).

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Selitrectinib

    go.drugbank.com/drugs/DB14896
    Investigational

    Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).

  9. Drug

    Retagliptin

    go.drugbank.com/drugs/DB14898
    Investigational

    Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).

  10. Drug

    JHU-75528 C-11

    go.drugbank.com/drugs/DB14902
    Investigational

    JHU-75528 C-11 is under investigation in clinical trial NCT03204305 (Brain Imaging of Cannabinoid Receptors).